Gadolinium Based Contrast Agents and NSF

By  

Current Rheumatology Reviews, Vol. 6, Iss. 3, 2010-08 ,pp. : 189-192

Bentham Science Publishers

Access to resources Recommend Favorite

Stability of linear and macrocyclic gadolinium based contrast agents

By Schmitt-Willich H  

British Journal of Radiology, Vol. 80, Iss. 955, 2007-07 ,pp. : 581-582

British Institute of Radiology

Access to resources Recommend Favorite

An investigation of the toxicity of gadolinium based MRI contrast agents using neutron activation analysis

By Bartolini M.E.   Pekar J.   Chettle D.R.   McNeill F.   Scott A.   Sykes J.   Prato F.S.   Moran G.R.  

Magnetic Resonance Imaging, Vol. 21, Iss. 5, 2003-06 ,pp. : 541-544

Elsevier

Access to resources Recommend Favorite

Detection of Coronary Stenoses with Contrast Enhanced, Three-Dimensional Free Breathing Coronary MR Angiography Using the Gadolinium-Based Intravascular Contrast Agent Gadocoletic Acid (B-22956)

By Paetsch Ingo   Jahnke Cosima   Barkhausen Joerg   Spuentrup Elmar   Cavagna Friedrich   Schnackenburg Bernhard   Huber Michael   Stuber Matthias   Fleck Eckart   Nagel Eike  

Journal of Cardiovascular Magnetic Resonance, Vol. 8, Iss. 3, 2006-07 ,pp. : 509-516

Informa Healthcare

Access to resources Recommend Favorite

S K Morcos. Nephrogenic systemic fibrosis following the administration of extracellular gadolinium based contrast agents: is the stability of the contrast agent molecule an important factor in the pathogenesis of this condition? (Br J Radiol 2007;80:73–6)

By  

British Journal of Radiology, Vol. 80, Iss. 955, 2007-07 ,pp. : 586-586

British Institute of Radiology

Access to resources Recommend Favorite